DATROWAY® (datopotamab deruxtecan-dlnk) has been approved in the U.S. for the treatment of adult patients with unresectable or metastatic hormone receptor (HR) positive, HER2 negative (IHC 0, IHC 1+ ...

DXd, has been approved in the US for the treatment of adult patients with unresectable or metastatic hormone receptor HR-positive, HER2-negative breast cancer who have received prior endocrine-based ...

Sex-related differences in pulmonary complications were found among men vs women with SSc, specifically in the prevalence of ILD and SAD.

But many existing models fall short of adhering to established best practices for economic evaluation, the review authors ...

Mayo Clinic researchers find that stem cells with the highest Myc expression become dominant in driving lung remodeling .

Amgen today announced that the U.S. Food and Drug Administration (FDA) has approved LUMAKRAS® (sotorasib) in combination with Vectibix® (panitumumab) for the treatment of adult patients with KRAS G12C ...

Virginia G. Kaklamani, MD, DSc, discusses findings from the phase 3 TROPION-Breast01 trial of datopotamab deruxtecan.

The approval is based on findings from the phase 3, multicenter, open-label, randomized TROPION-Breast01 trial.

Pivotal Study Demonstrated the Combination More Than Doubled Progression-Free Survival Compared to Investigated SOC THOUSAND OAKS, Calif., Jan. 17, 2025 /PRNewswire/ ...

The Food and Drug Administration (FDA) this month released a new proposed rule requiring tobacco companies to reduce the ...

Dr Zaheer Mangera shares insights into the lung cancer pathway and the benefits and challenges of early diagnosis and lung ...

A summary of the clinical characteristics and treatment strategies of patients with anti-MDA5+DM with different HRCT patterns is provided in table 2. Patients with NSIP+OP pattern had a shorter time ...